8/6/2009

Impax Laboratories gained FDA approval for a 500-milligram extended-release generic of Depakote, Abbott Laboratories' treatment for epilepsy and bipolar disorder. Impax said it intends to launch the drug immediately at 250 and 500 milligrams.

Related Summaries